Bruno Crestani Selected Research

Bruno Crestani Research Topics

Disease

58	Idiopathic Pulmonary Fibrosis 01/2022 - 04/2003
34	Fibrosis (Cirrhosis) 01/2022 - 06/2005
33	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 08/2002
10	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2007
10	Lung Injury 01/2021 - 03/2002
10	Inflammation (Inflammations) 01/2020 - 01/2002
8	Asthma (Bronchial Asthma) 06/2022 - 01/2002
8	Disease Progression 01/2021 - 02/2015
8	Lung Diseases (Lung Disease) 09/2019 - 03/2002
7	Neoplasms (Cancer) 01/2022 - 03/2003
7	Pneumonia (Pneumonitis) 11/2021 - 02/2002
7	Respiratory Insufficiency (Respiratory Failure) 01/2017 - 02/2002
6	Emphysema 01/2022 - 04/2005
6	Infections 01/2022 - 01/2010
6	Microscopic Polyangiitis 01/2018 - 10/2008
5	Acute Lung Injury 07/2012 - 03/2002
4	Lung Neoplasms (Lung Cancer) 10/2021 - 01/2016
4	Sarcoidosis (Schaumann Disease) 09/2020 - 11/2016
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018 - 07/2012
4	Vasculitis (Vasculitides) 01/2018 - 03/2016
3	Cysts 06/2020 - 09/2011
3	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019 - 05/2007
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2019 - 11/2014
3	Churg-Strauss Syndrome (Allergic Angiitis) 11/2017 - 03/2016
3	Chronic Obstructive Pulmonary Disease (COPD) 08/2011 - 01/2002
3	Pulmonary Emphysema 01/2008 - 04/2005
2	Weight Loss (Weight Reduction) 01/2022 - 11/2020
2	COVID-19 11/2021 - 01/2020
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 01/2017
2	Rheumatoid Arthritis 01/2021 - 06/2011
2	Dyspnea (Shortness of Breath) 11/2020 - 02/2016
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 10/2020 - 01/2020
2	Idiopathic Interstitial Pneumonias 01/2020 - 01/2017
2	Human Influenza (Influenza) 10/2019 - 12/2016
2	Adenocarcinoma 01/2019 - 03/2003
2	Adenocarcinoma of Lung 01/2019 - 04/2016
2	Drug-Related Side Effects and Adverse Reactions 01/2019 - 01/2015
2	Hemorrhage 01/2019 - 01/2019
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017 - 03/2016
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2017 - 01/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 11/2016
2	Hypertension (High Blood Pressure) 01/2016 - 08/2011

Drug/Important Bio-Agent (IBA)

18	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 02/2007
14	nintedanibIBA 01/2021 - 11/2014
11	pirfenidoneIBA 01/2022 - 06/2005
11	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2018 - 02/2002
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2005
6	Carbon MonoxideIBA 01/2022 - 04/2003
6	CollagenIBA 01/2022 - 09/2010
6	AntibodiesIBA 01/2022 - 01/2013
6	Biological ProductsIBA 01/2022 - 12/2007
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2013
5	SteroidsIBA 06/2020 - 10/2011
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2002
5	CytokinesIBA 01/2020 - 04/2002
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018 - 10/2008
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 04/2015
4	GlucocorticoidsIBA 01/2022 - 11/2014
4	Surface-Active Agents (Surfactants)IBA 10/2021 - 01/2018
4	EnzymesIBA 06/2021 - 09/2010
4	AntigensIBA 02/2021 - 10/2016
4	Hydroxyproline (4 Hydroxyproline)IBA 01/2021 - 06/2015
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 12/2012
4	telomerase RNA (bTR)IBA 01/2018 - 08/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 06/2005
4	indium-bleomycinIBA 06/2015 - 03/2010
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2005
3	Pharmaceutical PreparationsIBA 01/2021 - 06/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2003
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2021 - 01/2015
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021 - 08/2010
3	Immunoglobulin G (IgG)IBA 12/2018 - 03/2011
3	Transcription Factors (Transcription Factor)IBA 07/2018 - 08/2011
3	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 11/2007
3	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 04/2009
3	human airway trypsin-like proteaseIBA 01/2018 - 01/2017
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2017 - 06/2005
3	InterferonsIBA 12/2016 - 04/2003
3	Sirolimus (Rapamycin)FDA Link 09/2011 - 01/2007
3	Fibroblast Growth Factor 7 FDA Link 11/2007 - 04/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 04/2019
2	A-Form DNA (A-DNA)IBA 02/2021 - 08/2015
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2017
2	Immunoglobulin E (IgE)IBA 01/2021 - 10/2016
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2019
2	Rituximab (Mabthera)FDA Link 10/2020 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2020 - 03/2002
2	lipoarabinomannan (LAM)IBA 01/2019 - 09/2011
2	Fibronectins (Fibronectin)IBA 07/2018 - 11/2014
2	matriptaseIBA 01/2018 - 04/2016
2	AutoantibodiesIBA 01/2018 - 06/2011
2	InflammasomesIBA 12/2016 - 09/2010
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2016 - 03/2012

Therapy/Procedure

20	Therapeutics 01/2022 - 04/2003
7	Lung Transplantation 01/2022 - 04/2003
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 03/2002
2	Aftercare (After-Treatment) 01/2022 - 09/2011
2	Remission Induction 11/2017 - 01/2017
2	Pleurodesis 01/2017 - 04/2014